News | Computed Tomography (CT) | October 26, 2016

Frost & Sullivan Awards Carestream Top Honors for OnSight 3-D Extremity System

Company says advanced high-resolution CT scanner for weight-bearing examinations offers innovative design, improved productivity and advanced image reconstruction

Carestream, Frost & Sullivan, 2016 North American Frost & Sullivan Award for New Product Innovation, OnSight 3-D Extremity System, cone beam computed tomography, CBCT

October 26, 2016 — Based on its recent analysis of the computerized tomography (CT) market for extremity imaging, Frost & Sullivan recognizes Carestream Health with the 2016 North American Frost & Sullivan Award for New Product Innovation. Carestream's U.S. Food and Drug Administration (FDA)-approved cone beam computerized tomography (CBCT) device, the OnSight 3-D Extremity System, is proving to be a game-changer with its ergonomic design and unparalleled features, according to Frost & Sullivan. Compared to multi-detector computerized tomography (MDCT) systems, this device delivers lower dosage and provides the ability to capture weight-bearing images.

The system’s intuitive design is distinct from conventional doughnut-shaped CT scanners. It consists of a wide door opening that provides easy, step-in patient access. The large imaging bore accommodates heavier patients, while enabling a wide field-of-view image capture. To facilitate convenient equipment positioning, it has a dual-side positioning joystick. On the top of the device, two detachable patient-support handles enhance safety and comfort. Finally, a monitor attached to the system displays the patient’s demographic details and the imaging status for individualized diagnoses of extremities.

"Carestream’s OnSight 3-D Extremity System utilizes advanced interactive reconstruction techniques and generates exceptional image quality in both bone and soft tissue,” said Frost & Sullivan Research Analyst Karan Verma. "Similarly, weight-bearing applications are better evaluated using this system. By delivering volumetric reconstruction that has isotropic spatial resolution in all three directions, it bridges the gap between the market and customer needs."

The system produces 3-D images of high diagnostic value at the point of care to evaluate subtle or occult fractures and their healing. The device can improve the visibility of patient anatomy even in the presence of metal implants, which are a common cause of noise in CT images. It improves workflow and productivity due to its ability to perform both 2-D and 3-D scans on the same device.

Carestream’s device expedites patient scans as it has a fast equipment setup option with pre-programmed auto-positions. The system will typically not require a large shielded room or specialized electrical service, enhancing the ease and cost effectiveness of the installation.

For the OnSight 3-D Extremity System, the company has a dedicated team that provides technical assistance to medical professionals in hospitals and private clinics.

For more information: www.carestream.com

Related Content

New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Example of an intentionally truncated CT image

Figure 1: Example of an intentionally truncated CT image. The truncation percentage was calculated as the ratio of the patient border touching the field of view to the total patient border (red/(read+blue)). Image courtesy of Qaelum.

Feature | Radiation Dose Management | July 15, 2019 | Niki Fitousi, Ph.D., and An Dedulle
One of the main benefits of a radiation dose management system is the possibility to automatically generate alerts when...
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Cardiac Imaging | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology
News | Cardiac Imaging | July 08, 2019
Jonathon A. Leipsic, M.D., FSCCT, is the recipient of the 2019 DeHaan Award for Innovation in Cardiology, announced by...
vRad Presents AI Model to Assess Probability of Aortic Dissection
News | Artificial Intelligence | July 01, 2019
vRad (Virtual Radiologic), a Mednax company recently made a scientific presentation, “Screening for Aortic Dissection...
ClariPi Gets FDA Clearance for AI-powered CT Image Denoising Solution
Technology | Computed Tomography (CT) | June 24, 2019
Artificial intelligence (AI) imaging solution form ClariPi Inc. has received U.S. Food and Drug Administration (FDA)...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...